The role of gold weight implants in the management of paralytic lagophthalmos

Background/aim: The study aims to evaluate the usage of gold weight implants and monitor complaints and comfort of patients. Materials and methods: A hundred and ninety-one implantations performed between January 2009 and January 2019 were analyzed. Seventy-eight patients included in this study The average age of the patients was 51.3 ± 14.5 years. Forty-five (57.7%) of them were male and 33 (42.3%) female. Patient satisfaction was measured with a questionnaire containing the most common complaints related to gold weight in the literature through telephone surveys. Results: The average follow-up time was 74.5 months. Ninety-three-point-five percent of subjects had operational causes, among which the most widespread was acoustic neuroma (44.9%). The average time between facial paralysis and implantation was 141.1 days. Implantation was performed 26.6 days on average after acoustic neuroma surgery and 3.2 days on average after temporal zone malignancy surgery. Thirty-eight patients had their implants removed over either complication (n = 14) or recovery (n = 24). Recovery was the fastest after facial nerve decompression (mean= 4.75 ± 3.6 (2–10) months) and the slowest after 7–12 cranial nerve transfer (mean= 18.3 ± 8.2 (3–31) months). Twenty-six-point-nine percent (n = 21) of patients had complications, of which the most common was extrusion (n = 10). The overall satisfaction rate was 88.5% with the highest in visual acuity and the lowest in continuous requirement for artificial tear. Conclusion: The gold weight implantation is an effective, reversible, and easy procedure significantly reducing complaints regarding paralytic lagophthalmos. Early implementation may be beneficial for ocular complications. A dynamic facial reanimation could terminate need of implant.Key words: Gold weight implant, facial nerve paralysis, facial nerve, facial reanimation, acoustic neuroma

___

  • 1. Sharon JD, Kraus CL, Ehrenburg M, Weinreich HM, Francis HW. Risk assessment and prevention of corneal complications after lateral skull base surgery. Otology and Neurotology 2016; 37 (8): 1148-1154. doi: 10.1097/MAO.0000000000001123
  • 2. Flint, PW, Cummings CW. Cummings Otolaryngology Head & Neck Surgery. 6th Ed. USA: Saunders; 2015.
  • 3. Choi HY, Hong SE, Lew JM. Long-term comparison of a newly designed gold implant with the conventional implant in facial nerve paralysis. Plastic and Reconstructive Surgery 1999; 104 (6): 1624-1634. doi: 10.1097/00006534-199911000-00003
  • 4. Robinson MW, Baiungo J. Facial Rehabilitation: evaluation and treatment strategies for the patient with facial palsy. Otolaryngologic Clinics of North America 2018; 51 (6): 1151- 1167. doi: 10.1016/j.otc.2018.07.011
  • 5. Smellie GD. Restoration of the blinking reflex in facial palsy by a simple lid-load operation. British Journal of Plastic Surgery 1966; 19 (3): 279-283. doi: 10.1016/s0007-1226(66)80056-5
  • 6. Bair RL, Harris GJ, Lyon DB, Komorowski RA. Noninfectious inflammatory response to gold weight eyelid implants. Ophthalmic Plastic and Reconstructive Surgery 1995; 11 (3): 209-214. doi: 10.1097/00002341-199509000-00008
  • 7. Sonmez A, Ozturk N, Durmus N, Bayramicli M, Numanoglu A. Patients’ perspectives on the ocular symptoms of facial paralysis after gold weight implantation. Journal of Plastic, Reconstructive and Aesthetic Surgery 2008; 61 (9): 1065-1068. doi: 10.1016/j.bjps.2007.06.019
  • 8. Foda HM. Surgical management of lagophthalmos in patients with facial palsy. American Journal of Otolaryngology 1999; 20 (6): 391-395. doi: 10.1016/S0196-0709(99)90079-0
  • 9. Misra A, Grover R, Withey S, Grobbelaar AO, Harrison DH. Reducing postoperative morbidity after the insertion of gold weights to treat lagophthalmos. Annals of Plastic Surgery 2000; 45 (6): 623-628. doi: 10.1097/00000637-200045060-00009
  • 10. Pickford MA, Scamp T, Harrison DH. Morbidity after gold weight insertion into the upper eyelid in facial palsy. British Journal of Plastic Surgery 1992; 45 (6): 460-464. doi: 10.1016/0007-1226(92)90210-o
  • 11. May M. Gold weight and wire spring implants as alternatives to tarsorrhaphy. Archives of Otolaryngology Head Neck Surgery 1987; 113 (6): 656-660. doi: 10.1001/ archotol.1987.01860060082020
  • 12. Kelley SA, Sharpe DT. Gold eyelid weights in patients with facial palsy: a patient review. Plastic Reconstructive Surgery 1992; 89 (3): 436-440. doi: 10.1097/00006534-199203000-00006
  • 13. Rofagha S, Seiff SR. Long-term results for the use of gold eyelid load weights in the management of facial paralysis. Plastic Reconstructive Surgery 2010; 125 (1):142-149. doi: 10.1097/ PRS.0b013e3181c2a4f2
  • 14. Lavy JA, East CA, Bamber A, Andrews PJ. Gold weight implants in the management of lagophthalmos in facial palsy. Clinical Otolaryngology and Allied Science 2004; 29 (3): 279- 283. doi: 10.1111/j.1365-2273.2004.00817.x
  • 15. Pausch NC, Kuhnt CP, Halama D. Upper-eyelid weight implants for patients with lagophthalmos-comparison of rigid and flexible implants. Journal of Craniomaxillofacial Surgery 2018; 46 (10):1 843-1849. doi: 10.1016/j.jcms.2018.07.015
  • 16. Braun T, Batran H, Zengel P, Berghaus A, Hempel JM. Surgical rehabilitation of paralytic lagophthalmus by platinum chain lid loading: focusing on patient benefit and health-related quality of life. Otology and Neurotology 2012; 33 (9): 1630-1634. doi: 10.1097/mao.0b013e3182713938
  • 17. Gardner TA, Rak KM. Magnetic resonance imaging of eyelid springs and gold weights. Archives of Ophthalmology 1991; 109 (11): 1498. doi: 10.1001/archopht.1991.01080110032020
  • 18. Canady JW, Meine J, Thompson SA, Yuh WT. Effects of magnetic resonance imaging fields on gold eyelid loads. Annals of Plastic Surgery 1993; 31 (1): 76-77.
  • 19. Aggarwal E, Naik MN, Honavar SG. Effectiveness of the gold weight trial procedure in predicting the ideal weight for lid loading in facial palsy: a prospective study. American Journal of Ophthalmology 2007; 143 (6): 1009-1012. doi: 10.1016/j. ajo.2007.03.026
  • 20. Harrisberg BP, Singh RP, Croxson GR, Taylor RF, McCluskey PJ. Long-term outcome of gold eyelid weights in patients with facial nerve palsy. Otology and Neurotology 2001; 22 (3): 397- 400. doi: 10.1097/00129492-200105000-00022
  • 21. Jobe R. Gold lid loads. Plastic Reconstructive Surgery 1993; 91 (3): 563-564.
  • 22. Bhatti AF, Page K, Orlando A. Modification of the goldweight implant for insertion into the upper eyelid in facial palsy. Annals of Plastic Surgery 2005; 55 (6): 689-692. doi: 10.1097/01.sap.0000186511.74167.4e
  • 23. O’Connell JE, Robin PE. Eyelid gold weights in the management of facial palsy. Journal of Laryngology and Otology 1991; 105 (6): 471-474. doi: 10.1017/s0022215100116330
  • 24. Catalano PJ, Bergstein MJ, Biller HF. Comprehensive management of the eye in facial paralysis. Archives of Otolaryngology, Head Neck Surgery 1995; 121 (1): 81-86. doi: 10.1001/archotol.1995.01890010063011
  • 25. Gladstone GJ, Nesi FA. Management of paralytic lagophthalmos with a modified gold-weight implantation technique. Ophthalmic Plastic Reconstructive Surgery 1996; 12 (1): 38- 44. doi: 10.1097/00002341-199603000-00006
  • 26. Kartush JM, Linstrom CJ, McCann PM, Graham MD. Early gold weight eyelid implantation for facial paralysis. Otolaryngology, Head Neck Surgery 1990; 103 (6): 1016-1023. doi: 10.1177/019459989010300622
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Risk of autism spectrum disorder in children with a history of hospitalization for neonatal jaundice

Ayla UZUN ÇİÇEK, Gaffari TUNÇ, Fatih KILIÇBAY

Country-based report: the safety of omalizumab treatment in pregnant patients with asthma

Sevim BAVBEK, Bilun GEMİCİOĞLU, Arzu YORGANCIOĞLU, Yavuz HAVLUCU, Gül KARAKAYA, Zeynep Ferhan ÖZŞEKER, Dane EDİGER, Arzu Didem YALÇIN, Levent ÖZDEMİR, Metin KEREN, İpek Kıvılcım OĞUZÜLGEN

What is the restorative effect of VEGF inhibitor bevacuzimab against subarachnoid hemorrhage in an experimental model?

Ersin ÖZEREN, Yahya GÜVENÇ, Adnan Yalçın DEMİRC, Çetin AKYOL, Pınar BAYRAM, Deniz BİLLUR, Sevim AYDIN, Hakan SEÇKİN, Kazım YİĞİTKANLI

The effects of vitamin D supplemantation on prognosis in patients with mild obstructive sleep apnea syndrome

Özlem GÜLBAHAR, Nigar AFANDIYEVA, Feride AYYILDIZ, Hilal YILDIRAN, Oğuz KÖKTÜRK

Relationship between c-reactive protein to albumin ratio and coronary artery calcium score and CAD-RADS scores with coronary computed tomography angiography

Mehmet Akif ERDÖL, Kadriye GAYRETLİ YAYLA

Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience

QingXiao SU, YuHeng LIANG, Na WANG, ZhiYan DOU, Xue ZHAO, Bo YU, YuXue WANG, XinLiang WANG

Translation and validation of a Turkish version of the Xerostomia Inventory XI in patients with primary Sjögren’s syndrome

Veli ÇOBANKARA, Hande ŞENOL, Aylin KESKİN, Sinem BOZCUK, Elif GÜR KABUL, Bilge BAŞAKCI ÇALIK

High mobility group box- 1 levels may be associated with disease activity of Behcet’s disease

Tahsin Murat TURGAY, Müçteba Enes YAYLA, Murat TORGUTALP, İlyas Ercan OKATAN, Gülay KINIKLI, Didem ŞAHİN EROĞLU, Serdar SEZER, Ayşe Bahar KELEŞOĞLU DİNÇER, Emine Gözde AYDEMİR GÜLÖKSÜZ, Mehmet Levent YÜKSEL, Aşkın ATEŞ, Dilara DÖNMEZ GÜLER, Hasan Selim GÜLER, Zeynep Ceren KARAHAN

Nondamaging retinal laser therapy in recurrent diabetic macular edema after antiVEGF injections

Mehmet ÇITIRIK

Dual energy CT in necrotizing enterocolitis; a novel diagnostic approach

Mustafa KARA, Özgür ÇAĞLAR, Binali FIRINCI, Mehmet Emin ÇELİKKAYA, Recep SADE, Emrullah CESUR, Akgün ORAL, Murat YİĞİTER, Sevilay ÖZMEN